$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
7 Drug Stocks to Buy Now While They're Still on Sale
02:29pm, Tuesday, 30'th Nov 2021
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead. The post 7 Drug Stocks to Buy Now While They're Still on Sale appe
BioMark Diagnostics, Inc.: BioMark to Collaborate with Astrazeneca, Pfizer Canada and The IUCPQ Foundation in a $3.5m Project to Improve Early Detection of Lung Cancer
01:32pm, Tuesday, 30'th Nov 2021 FinanzNachrichten
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced stage liquid biopsy company with a focu
AstraZeneca breakthrough as Oxford Uni say no evidence Omicron can escape vaccine
01:17pm, Tuesday, 30'th Nov 2021 Newslanes
ASTRAZENECA is poised for a huge win as Oxford University scientists say there is no evidence yet that the new Omicron variant can escape their vaccine. Read more here Daily Express :: Science Feed AstraZeneca breakthrough as Oxford Uni say no evidence Omicron can escape vaccine
AstraZeneca-Merck''s Lynparza Under FDA Priority Review For Breast Cancer Setting
12:59pm, Tuesday, 30'th Nov 2021 Benzinga
The FDA has granted priority review for AstraZeneca Plc''s (NASDAQ: AZN ) supplemental marketing application for Lynparza (olaparib) for breast cancer. The application for Lynparza covers the adjuvant treatment of patients with BRCA -mutated ( BRCA m) HER2-negative high-risk early breast cancer who have already been treated with chemotherapy either before or after surgery. Lynparza is being jointly developed and commercialized by AstraZeneca and Merck & Co Inc (NYSE: Full story available on Benzinga.com
Inflammation is a process by which your body''s white blood cells and the things they make protect you from infection from outside invaders, such as bacteria and viruses. Although it is not proven that inflammation causes cardiovascular disease, inflammation is
Acute migraine is a general term for a migraine attack that isn''t diagnosed as chronic. Another name for this type is episodic migraine. People who have episodic migraine have attacks up to 14 days a month. Thus, people with episodic
Market Overview: A pharmaceuticals drug is any drug used in the diagnosis, treatment, prevention or the cure of disease. Pharmacy has been one of the most prominent and significant contributions to modern medicine. Pharmacy is a key part of the medical
Fast Melt Tablet Market is booming at a healthy CAGR +9% by the time lapse of 2021-28. A fast-dissolving drug delivery system, in most cases, is a tablet that dissolves or disintegrates quickly in the oral cavity upon the contact with
AstraZeneca breakthrough as Oxford Uni say ''no evidence'' Omicron can escape vaccine
11:48am, Tuesday, 30'th Nov 2021 Daily Express
ASTRAZENECA is poised for a huge win as Oxford University scientists say there is "no evidence" yet that the new Omicron variant can escape their vaccine.
FDA accepts AstraZeneca/Merck''s Lynparza for priority review for breast cancer
11:39am, Tuesday, 30'th Nov 2021 Seeking AlphaLYNPARZA® (olaparib) Granted Priority Review in the US for BRCA-Mutated HER2-Negative High-Risk Early Breast Cancer
11:30am, Tuesday, 30'th Nov 2021 Business Wire
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZenecas supplemental New Drug Application (sNDA) for LYNPARZA® (olaparib) has been accepted and granted Priority Review in the US for the adjuvant treatment of patients with BRCA-mutated (BRCAm) HER2-negative high-risk early breast cancer who have already been treated with chemotherapy either before or after surgery. LYNPARZA is being jointly developed and commercialized by AstraZeneca and Merck & Co., Inc., known as MSD outside the US and Canada. Th
COVAX offers 4.7 million more COVID-19 vaccine doses to North Korea
10:21am, Tuesday, 30'th Nov 2021 NK NEWS
COVAX has allocated 4.73 million more AstraZeneca (AZ) COVID-19 vaccines for North Korea, the global vaccine alliance Gavi confirmed to NK News on Tuesday. With around 2.1 million AZ vaccines previously assigned, COVAX has now pledged a total of around 6.83 million doses for North Korea but none have been delivered so far. Gavi []
Several African countries destroy COVID-19 vaccines-Africa CDC
08:21am, Tuesday, 30'th Nov 2021 Journal du Cameroun
A large quantity of Covid-19 vaccines will continue to go waste if Western countries keep on sending doses with shorter shelf lives, warned African CDC and its partners on Monday.Several African countries are destroying vaccines after they''ve exceeded their expiry dates. Others are being returned by countries that are unable to use them before they expire with Namibia becoming the latest nation that announced more than 268,000 doses of AstraZeneca and Pfizer COVID-19 vaccines are at risk of being destroyed in weeks. On Monday, the African Vaccine Acquisition Trust (AVAT), the Africa Centres for Disease Control and Prevention (Africa CDC) and COVAX issued a statement to draw the attention of the donors of COVID-19 vaccines to Africa, particularly those supported by the Gavi COVAX Advance Market Commitment, on the situation. To date, over 90 million donated doses have been delivered to the continent via COVAX and AVAT and millions more via bilateral arrangements. However, the majority of the donations to-date have been ad hoc, provided with little notice and short shelf lives, the trio said. This has made it extremely challenging for countries to plan vaccination campaigns and increase absorptive capacity. This trend must change in order o achieve higher coverage rates across the continent, and for donations to be a sustainable source of supply that can complement supply from AVAT and COVAX purchase agreements, they warned. Countries need predictable and reliable supply, the agencies said, adding having to plan at short notice and ensure uptake of doses with short shelf lives exponentially magnifies the logistical burden on health systems that are already stretched.
2 tranches of COVID-19 vaccines expected in December
07:50am, Tuesday, 30'th Nov 2021 Guyana Times
The Guyana Government is expecting two tranches of COVID-19 vaccines in December. Health Minister, Dr Frank Anthony on Monday noted that they are working with the COVAX mechanism to facilitate these shipments within the new month. The jabs currently being looked at includes Pfizer, AstraZeneca; and Johnson and Johnson. We are expecting some vaccines. We [] The post 2 tranches of COVID-19 vaccines expected in December appeared first on Guyana Times .
Coronavirus: Booster vaccinations for 30+ kick off
07:25am, Tuesday, 30'th Nov 2021 Cyprus Mail
Health authorities on Tuesday started administering Covid booster jabs to people aged 30 and above at walk-in centres or after appointment through the vaccination portal. People can receive the booster jab as long as six months have elapsed since the second dose of a Pfizer, Moderna, or AstraZeneca vaccine, or
Sign In
Buy AZN